Clin2
NCT07585669Possibly a fitRecruiting

Omega-3 Supplements for New Celiac Disease Patients

Celiac Disease

Part of Digestive system, Hormones & metabolism clinical trials.

This study tests whether omega-3 fatty acids (a type of fish oil supplement) can reduce inflammation and improve gut health in people newly diagnosed with celiac disease. Participants will follow a gluten-free diet while taking the supplement to see if it helps their body heal.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are 18–65 years old
  • You were recently diagnosed with celiac disease (confirmed by blood test and stomach biopsy)
  • You have not yet started a gluten-free diet
  • You are willing to follow a supervised gluten-free diet for the study duration
  • You have not taken omega-3 or anti-inflammatory supplements in the last 3 months
  • You do not have other gut diseases like Crohn's disease or ulcerative colitis

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06982963Recruiting· Phase 2
Study of an experimental drug for celiac disease

This study tests an experimental medication for adults with celiac disease to see if it can protect against gluten exposure. You will need to follow a gluten-free diet and undergo a short, planned gluten challenge.

Melbourne
NCT05576038Recruiting
Tryptophan to help celiac symptoms improve

This trial tests whether tryptophan (a natural amino acid) can improve symptoms in people with celiac disease who still have symptoms despite following a gluten-free diet. It may help by supporting an internal body signal pathway researchers believe is impaired in some people with celiac disease.

Hamilton, Ontario
NCT06059716Recruiting
Gluten detection and education for new celiac diagnosis

This study helps people newly diagnosed with celiac disease learn to use a gluten-detection device and get education to better manage their diet and health.

Chicago, Illinois
NCT07377565Recruiting· Phase 1
Testing a new diagnostic for celiac disease during endoscopy

This study tests a new medicine called HB-2121 used as a diagnostic tool during an upper endoscopy to help improve detection of celiac disease. It's designed for people who are already scheduled for this procedure and may help doctors see the gut damage caused by celiac more clearly.

Stanford, California
NCT07039773Recruiting
Gluten challenge in celiac disease: finding the best gluten type

This trial compares different forms of gluten to see which one causes the strongest immune reaction in people with celiac disease. It may help doctors choose the best way to test gluten sensitivity in the future.

Oslo, Oslo
NCT05680012Recruiting
Testing how gluten affects healing in celiac disease

This study looks at how the gut lining “tissues” are affected during gluten eating versus avoiding gluten in people with celiac disease. It may help researchers understand what drives healing and tissue damage in celiac disease.

Pasadena, California

Hear when a new Celiac Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.